Deciphering the Mechanism of Action of Drugs Targeting EGFR, by Cisbio’s Advanced Cell-Based Pathway Readout Assays

In this poster discover how Cisbio’s fluorescent sandwich immunoassay technology HTRF®, which is based on TR-FRET, was successfully applied to monitor the response of a pancreatic cancer cell line BxPC3, to increasing concentrations of EGFR inhibitors.